pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Jazz Pharmaceuticals plc ($JAZZ) · news · pharmadog
← back to Jazz Pharmaceuticals plc
News mentioning $JAZZ
48
stories
4d
8 companies hiring in North Carolina now
biospace
11d
BioNTech pays $205M for FDA voucher to speed up ‘late-stage oncology pipeline’
fiercebiotech
12d
BioSpace 2027 Best Places to Work shines light on most admired employers
biospace
18d
6 potential blockbusters that could pave China’s path to 2030 ambitions
biospace
23d
New biotech Setara forms with $90M to take on Jazz’s bonus rare disease programs
biospace
23d
Setara gets $90M to continue rare disease pipeline spun out of Jazz's Actio deal
endpoints
23d
With Setara, the team behind Actio opens its second act
biopharma dive
24d
Jazz's $820M Actio buyout gives rise to Setara, armed with $90M series A
fiercebiotech
27d
Aspen, Bambusa target $135M IPOs; AstraZeneca vs. Takeda in gastric cancer ADCs
endpoints
Oct 23, 26
Roche bets up to $813M on Zymeworks’ lung cancer trispecific T cell engager
biospace
Oct 21, 26
8 companies hiring remote workers
biospace
Oct 15, 26
Iambic goes public with $150M IPO to accelerate clinical development of oncology pipeline
fiercebiotech
Oct 15, 26
Iambic, an AI drug discovery specialist, banks $150M in an IPO
biopharma dive
Oct 14, 26
Jazz CEO calls on industry to help rebuild momentum for leadership diversity
biospace
Oct 13, 26
Analysts eye RevMed’s pancreatic cancer launch, Merck’s data blitz for Q3 earnings
biospace
Oct 8, 26
AI biotech Iambic aims for $135M IPO to push cancer drugs through clinic
fiercebiotech
Sep 25, 26
How Big Tobacco flooded the FDA with public comments to kill a menthol cigarette ban
stat
Sep 22, 26
An orexin drug’s ‘proof-of-concept’ in ADHD; Cue’s ‘unwarranted’ share slide
biopharma dive
Sep 22, 26
Iambic maintains momentum from string of Big Pharma partnerships by aiming for IPO
fiercebiotech
Sep 14, 26
Roche, MediLink notch phase 3 lung cancer win but trail GSK on cross-trial survival
fiercebiotech
Sep 9, 26
Beyond China: Five other overseas destinations for biopharma dollars
biospace
Sep 2, 26
UK regulator halts sales of Tavneos; UniQure seeks approval for Huntington's gene therapy
endpoints
Aug 27, 26
Roche nabs expanded FDA approval for diagnostic tied to Jazz’s cancer drug
fiercebiotech
Aug 26, 26
Jazz scores front-line gastric cancer nod from FDA for ‘practice-changing’ Ziihera
biospace
Aug 25, 26
New Jazz cancer drug approval could drive blockbuster sales
biopharma dive
Aug 25, 26
FDA approves Jazz's Ziihera in frontline gastric cancer
endpoints
Aug 25, 26
Recon: FDA expands labels for J&J’s Imaavy, Jazz's Ziihera; Teva faces Turkish antitrust probe over patent moves
raps
Aug 21, 26
Werewolf transforms into Ambros via reverse merger to support phase 3 push for rare disease drug
fiercebiotech
Aug 20, 26
Chutes & Ladders—Neumora shuffles leadership ahead of IND
fiercebiotech
Aug 19, 26
Takeda leads wave of orexin drugs with potential to upend narcolepsy market
biospace
← prev
page 1 of 2
next →